LYB Stock Analysis: LyondellBasell Industries | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 21.117m USD | 12M Return: 52.3% | NL0009434992 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 230M
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
LyondellBasell Industries N.V. (NYSE: LYB) is a Netherlands-headquartered chemical company incorporated in 2009 and listed in the U.S. since 2010. It operates across five segments-Olefins and Polyolefins (Americas, Europe/Asia/International), Intermediates and Derivatives, Advanced Polymer Solutions, and Technology-producing foundational chemicals such as ethylene, propylene, butadiene, polyethylene, and polypropylene, as well as specialty compounds, catalysts, and licensed process technologies. Its products serve diverse end markets including food packaging, home furnishings, automotive components, and paints and coatings, with operations spanning the United States, Europe, and Asia.
As a large-cap commodity chemicals producer within the Materials sector, LyondellBasell operates a vertically integrated business model that spans upstream olefin production, downstream polymer compounding, and a third-party technology licensing arm-a structure common among major petrochemical players. Its results are closely tied to global hydrocarbon feedstock prices and the cyclical demand patterns of the plastics and automotive industries.
- Polyolefin spreads compress on global oversupply and weak demand
- European energy costs pressure Olefins segment margins
- Share repurchases continue amid strong free cash flow
| Net Income: 1.32b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 12.91 > 1.0 |
| NWC/Revenue: 13.51% < 20% (prev 11.99%; Δ 1.52% < -1%) |
| CFO/TA 0.11 > 3% & CFO 3.71b > Net Income 1.32b |
| Net Debt (11.2b) to EBITDA (4.20b): 2.66 < 3 |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (304.7m) vs 12m ago -6.53% < -2% |
| Gross Margin: 9.56% > 18% (prev 9.23%; Δ 0.34% > 0.5%) |
| Asset Turnover: 88.96% > 50% (prev 96.37%; Δ -7.41% > 0%) |
| Interest Coverage Ratio: 5.62 > 6 (EBIT TTM 2.81b / Interest Expense TTM 500.0m) |
| A: 0.12 (Total Current Assets 10.9b - Total Current Liabilities 6.79b) / Total Assets 34.0b |
| B: 0.22 (Retained Earnings 7.58b / Total Assets 34.0b) |
| C: 0.08 (EBIT TTM 2.81b / Avg Total Assets 33.9b) |
| D: 0.52 (Book Value of Equity 11.3b / Total Liabilities 21.6b) |
| Altman-Z'' = 2.62 = A |
As of November 09, 2026, the stock is trading at USD 60.72 with a total of 3,018,390 shares traded. Over the past week, the price has changed by -11.54%, over one month by +3.04%, over three months by -0.15% and over the past year by +52.30%.
Current recommended Stop Loss: 56.10 (which is 7.6% or 2 ATR below the current price).
LyondellBasell Industries has received a consensus analysts rating of 3.15. Therefore, it is recommended to hold LYB.
- StrongBuy: 2
- Buy: 4
- Hold: 11
- Sell: 1
- StrongSell: 2
| Analysts Target Price | 67.9 | 11.8% |
P/E Forward = 10.2775
P/S = 0.677
P/B = 2.0322
P/EG = 0.8541
Revenue TTM = 30.2b USD
EBIT TTM = 2.81b USD
EBITDA TTM = 4.20b USD
Long Term Debt = 12.1b USD (from longTermDebt, last fiscal year)
Short Term Debt = 891.0m USD (from shortTermDebt, last quarter)
Debt = 14.6b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.31b
Net Debt = 11.2b USD (calculated: Debt 14.6b - CCE 3.44b)
Enterprise Value = 32.3b USD (21.1b + Debt 14.6b - CCE 3.44b)
Interest Coverage Ratio = 5.62 (Ebit TTM 2.81b / Interest Expense TTM 500.0m)
EV/FCF = 6.29x (Enterprise Value 32.3b / FCF TTM 5.13b)
FCF Yield = 15.89% (FCF TTM 5.13b / Enterprise Value 32.3b)
FCF Margin = 17.03% (FCF TTM 5.13b / Revenue TTM 30.2b)
Net Margin = 4.37% (Net Income TTM 1.32b / Revenue TTM 30.2b)
Gross Margin = 9.56% ((Revenue TTM 30.2b - Cost of Revenue TTM 27.3b) / Revenue TTM)
Gross Margin QoQ = none% (prev 22.21%)
Tobins Q-Ratio = 0.95 (Enterprise Value 32.3b / Total Assets 34.0b)
Interest Expense / Debt = 3.42% (Interest Expense 500.0m / Debt 14.6b)
Taxrate = 23.54% (414.0m / 1.76b)
NOPAT = 2.15b (EBIT 2.81b * (1 - 23.54%))
Current Ratio = 1.60 (Total Current Assets 10.9b / Total Current Liabilities 6.79b)
Debt / Equity = 1.30 (Debt 14.6b / totalStockholderEquity, last quarter 11.3b)
Debt / EBITDA = 2.66 (Net Debt 11.2b / EBITDA 4.20b)
Debt / FCF = 2.18 (Net Debt 11.2b / FCF TTM 5.13b)
Total Stockholder Equity = 10.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 1.32b / Total Assets 34.0b)
RoE = 12.54% (Net Income TTM 1.32b / Total Stockholder Equity 10.5b)
RoCE = 12.41% (EBIT 2.81b / Capital Employed (Equity 10.5b + L.T.Debt 12.1b))
RoIC = 8.08% (NOPAT 2.15b / Invested Capital 26.6b)
WACC = 5.32% (E(21.1b)/V(35.7b) * Re(7.20%) + D(14.6b)/V(35.7b) * Rd(3.42%) * (1-Tc(0.24)))
Discount Rate = 7.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -65.88 | Cagr: -2.95%
[DCF] Terminal Value 77.97% ; FCFF base≈3.38b ; Y1≈3.87b ; Y5≈5.69b
[DCF] Fair Price = 230.7 (EV 85.7b - Net Debt 11.2b = Equity 74.5b / Shares 323.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -55.26 | EPS CAGR: -29.40% | SUE: -0.52 | # QB: 0
Revenue Correlation: -97.50 | Revenue CAGR: -11.56% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=9.15 | Chg30d=+1.23% | Revisions=-73% | GrowthEPS=+438.2% | GrowthRev=+10.4%
EPS next Year (2027-12-31): EPS=6.34 | Chg30d=+0.52% | Revisions=-44% | GrowthEPS=-30.7% | GrowthRev=-2.7%
[Analyst] Revisions Ratio: -71% (up=1, down=13)